硫醇饥饿会以ATF4和NRF2依赖的方式触发黑色素瘤状态的切换
Madlen Meinert1, Christina Jessen2, Anita Hufnagel2
1Department of Physiological Chemistry, University of Würzburg, Würzburg, Germany.
Redox biology
|January 14, 2024
概括
黑色素瘤细胞通过激活抗氧化剂和新合成途径来适应减少的氨酸供应. 这种由NRF2和ATF4驱动的适应促进了更具侵入性的细胞表型.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 氨酸/谷氨酸抗载体xCT提供氨酸,这对氨酸的合成和癌细胞中氧化应激防御至关重要.
- 黑色素瘤特别容易受到氧化应激的影响,这凸显了囊和谷氨代谢的重要性.
研究的目的:
- 调查xCT介导的氨酸和谷氨供应在黑色素瘤中的作用.
- 了解黑色素瘤中xCT活性改变的适应机制和表型后果.
主要方法:
- 在小鼠黑色素瘤模型中xCT的遗传枯竭和细胞系中的急性囊素缺失.
- RNA测序以分析对xCT抑制的反应中的基因表达变化.
- 对抗氧化剂防御的分析,新型氨酸生物合成和表型标记.
主要成果:
- 抑制xCT显著降低了谷氨水平,但被黑色素瘤细胞容忍.
- 适应性上调NRF2和ATF4通道补偿了囊缺乏症.
- 结合NRF2和ATF4激活诱导了表型转向减少分化和增加入侵.
结论:
- 黑色素瘤细胞表现出显著的表型可塑性,以应对改变的氨酸/氨酸水平.
- NRF2和ATF4通路是黑色素瘤适应和侵袭的关键调节者.
- 向xCT或谷氨合成可能会影响黑色素瘤的进展和侵袭性.
更多相关视频
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
6.9K
06:09Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
8.7K
相关概念视频
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
